Beneficial effects of autologous mesenchymal stem cell transplantation in active progressive multiple sclerosis

Deep gray matter volume loss drives disability worsening in multiple sclerosis

(2018) Arman Eshaghi et al.   ANNALS OF NEUROLOGY

Clinical feasibility of umbilical cord tissue-derived mesenchymal stem cells in the treatment of multiple sclerosis

(2018) Neil H. Riordan et al.   Journal of Translational Medicine

Multiple Sclerosis

(2018) Daniel S. Reich et al.   NEW ENGLAND JOURNAL OF MEDICINE

Adipose-derived mesenchymal stem cells (AdMSC) for the treatment of secondary-progressive multiple sclerosis: A triple blinded, placebo controlled, randomized phase I/II safety and feasibility study

(2018) Oscar Fernández et al.   PLoS One

Phase I Trial of Intrathecal Mesenchymal Stem Cell-derived Neural Progenitors in Progressive Multiple Sclerosis

(2018) Violaine K. Harris et al.   EBioMedicine

Pilot trial of intravenous autologous culture-expanded mesenchymal stem cell transplantation in multiple sclerosis

(2017) Jeffrey A Cohen et al.   Multiple Sclerosis Journal

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis

(2017) Xavier Montalban et al.   NEW ENGLAND JOURNAL OF MEDICINE

Pilot trial of intravenous autologous culture-expanded mesenchymal stem cell transplantation in multiple sclerosis

(2017) Jeffrey A Cohen et al.   Multiple Sclerosis Journal

Clinical safety of intrathecal administration of mesenchymal stromal cell–derived neural progenitors in multiple sclerosis

(2016) Violaine K. Harris et al.   CYTOTHERAPY

MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study

(2016) Ayman Tourbah et al.   Multiple Sclerosis Journal

Inclusion of brain volume loss in a revised measure of ‘no evidence of disease activity’ (NEDA-4) in relapsing–remitting multiple sclerosis

(2016) Ludwig Kappos et al.   Multiple Sclerosis Journal

Therapeutic Advances and Future Prospects in Progressive Forms of Multiple Sclerosis

(2016) Afsaneh Shirani et al.   Neurotherapeutics

Clinical Outcomes of Transplanted Modified Bone Marrow–Derived Mesenchymal Stem Cells in Stroke

(2016) Gary K. Steinberg et al.   STROKE

Safety and Clinical Effects of Mesenchymal Stem Cells Secreting Neurotrophic Factor Transplantation in Patients With Amyotrophic Lateral Sclerosis

(2016) Panayiota Petrou et al.   JAMA Neurology

MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study

(2016) Ayman Tourbah et al.   Multiple Sclerosis Journal

Inclusion of brain volume loss in a revised measure of ‘no evidence of disease activity’ (NEDA-4) in relapsing–remitting multiple sclerosis

(2016) Ludwig Kappos et al.   Multiple Sclerosis Journal

Association of Deep Gray Matter Damage With Cortical and Spinal Cord Degeneration in Primary Progressive Multiple Sclerosis

(2015) Serena Ruggieri et al.   JAMA Neurology

Defining the clinical course of multiple sclerosis: The 2013 revisions

(2014) F. D. Lublin et al.   NEUROLOGY

Randomized Placebo-Controlled Phase II Trial of Autologous Mesenchymal Stem Cells in Multiple Sclerosis

(2014) Sara Llufriu et al.   PLoS One

Human placenta-derived cells (PDA-001) for the treatment of adults with multiple sclerosis: A randomized, placebo-controlled, multiple-dose study

(2014) Fred D. Lublin et al.   Multiple Sclerosis and Related Disorders

A randomized trial of mesenchymal stem cells in multiple system atrophy

(2012) Phil Hyu Lee et al.   ANNALS OF NEUROLOGY

Clinical experience with stem cells and other cell therapies in neurological diseases

(2012) Dimitrios Karussis et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Neurorepair with mesenchymal stem cells: hope or hype?

(2012) Mark S Freedman et al.   LANCET NEUROLOGY

Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study

(2012) Peter Connick et al.   LANCET NEUROLOGY

Clinical and pathological effects of intrathecal injection of mesenchymal stem cell-derived neural progenitors in an experimental model of multiple sclerosis

(2011) Violaine K. Harris et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Inflammatory Cortical Demyelination in Early Multiple Sclerosis

(2011) Claudia F. Lucchinetti et al.   NEW ENGLAND JOURNAL OF MEDICINE

Bone Marrow Mesenchymal Stem Cells: Agents of Immunomodulation and Neuroprotection

(2011) Ibrahim Kassis et al.   Current Stem Cell Research & Therapy

Mesenchymal Stem Cells for Multiple Sclerosis: Does Neural Differentiation Really Matter?

(2011) Antonio Uccelli et al.   Current Stem Cell Research & Therapy

Safety and Immunological Effects of Mesenchymal Stem Cell Transplantation in Patients With Multiple Sclerosis and Amyotrophic Lateral Sclerosis

(2010) Dimitrios Karussis et al.   ARCHIVES OF NEUROLOGY

Transplanted bone marrow stem cells relocate to infarct penumbra and co-express endogenous proliferative and immature neuronal markers in a mouse model of ischemic cerebral stroke

(2010) Xue-mei Zhang et al.   BMC NEUROSCIENCE

Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: A pilot study

(2010) Bassem Yamout et al.   JOURNAL OF NEUROIMMUNOLOGY

The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group

(2010) Mark S Freedman et al.   Multiple Sclerosis Journal

Human neural stem cells ameliorate autoimmune encephalomyelitis in non-human primates

(2009) Stefano Pluchino et al.   ANNALS OF NEUROLOGY

The Changing Face of Neural Stem Cell Therapy in Neurologic Diseases

(2008) Ofira Einstein et al.   ARCHIVES OF NEUROLOGY

Neuroprotection and Immunomodulation With Mesenchymal Stem Cells in Chronic Experimental Autoimmune Encephalomyelitis

(2008) Ibrahim Kassis et al.   ARCHIVES OF NEUROLOGY

The potential use of stem cells in multiple sclerosis: An overview of the preclinical experience

(2008) Dimitrios Karussis et al.   CLINICAL NEUROLOGY AND NEUROSURGERY

Neuroprotective Effect of Transplanted Human Embryonic Stem Cell-Derived Neural Precursors in an Animal Model of Multiple Sclerosis

(2008) Michal Aharonowiz et al.   PLoS One

Immunomodulation and neuroprotection with mesenchymal bone marrow stem cells (MSCs): A proposed treatment for multiple sclerosis and other neuroimmunological/neurodegenerative diseases

(2007) Dimitrios Karussis et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES